Lercanidipine Medreg

Lercanidipine, the active ingredient in Lercanidipine Medreg, is a calcium channel blocker presented as a tablet for oral use. It is used to treat hypertension in adult patients. GNH USA supplies Lercanidipine Medreg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lercanidipine is indicated for the management of high blood pressure within the antihypertensive drug class. - Hypertension: lowers elevated systolic and diastolic blood pressure to reduce cardiovascular risk. - Essential hypertension: provides long‑lasting blood pressure control in primary hypertension. - Isolated systolic hypertension: effectively reduces systolic pressure in elderly patients with isolated systolic elevation.

Lercanidipine may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Headache: mild to moderate pressure sensation. - Flushing: transient warmth and reddening of the skin. - Peripheral edema: swelling of ankles or lower legs. - Dizziness: sensation of light‑headedness, especially after standing. - Tachycardia: mild increase in heart rate. - Gastrointestinal discomfort: nausea or abdominal pain.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure causing fainting. - Angioedema: swelling of face, lips, tongue, or airway. - Myocardial infarction: rare occurrence of heart attack. - Hepatic dysfunction: abnormal liver enzyme elevations. - Allergic reactions: rash, pruritus, or urticaria. - Cardiac arrhythmias: irregular heart rhythms.

Before initiating therapy with Lercanidipine, consider the following safety measures. - Blood pressure monitoring: regularly assess to avoid excessive hypotension. - Hepatic impairment: use cautiously and adjust if liver function is compromised. - Elderly patients: start at the lowest effective dose and monitor for dizziness. - Concomitant antihypertensives: watch for additive blood‑pressure‑lowering effects. - Hypersensitivity: discontinue if signs of allergic reaction appear. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Lercanidipine can interact with several drug classes, influencing its efficacy and safety.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): may increase plasma levels and risk of hypotension. - Grapefruit juice: can markedly raise drug concentrations. - Other potent vasodilators (e.g., nitroglycerin): may cause severe blood‑pressure drops.

Moderate Interactions (Monitor Closely):\n- CYP3A4 inducers (e.g., rifampicin, carbamazepine): may reduce effectiveness. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): can blunt antihypertensive response. - Diuretics and beta‑blockers: require careful titration to avoid excessive hypotension.